David Holland - Alimera Sciences Insider

Alimera Sciences Inc -- USA Stock  

USD 1.3  0.01  0.76%

Co-Founder and Sr. VP of Sales and Marketing

Mr. David R. Holland is the Senior Vice President Sales and Marketing of Alimera Sciences, Inc. Prior cofounders and served as the Vice President of Marketing since the founding of our Company in 2003 through August 2010 when he was appointed the Senior Vice President of Sales and Marketing. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.
Age: 51  Founder Since 2010      
678-990-5740  www.alimerasciences.com

David Holland Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (14.38) % which means that it has lost $14.38 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (81.51) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.4 M in liabilities with Debt to Equity (D/E) ratio of 165.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alimera Sciences Inc has Current Ratio of 4.74 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. Alimera Sciences Inc (ALIM) is traded on NASDAQ General Markets in USA. It is located in GEORGIA, U.S.A and employs 125 people. Alimera Sciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Fundamentals Matrix Now

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
Hide  View All  NextLaunch Fundamentals Matrix
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Alimera Sciences Inc to your portfolio

Top Management

Alimera Sciences Inc Leadership Team
James Largent, Director, MBA
Peter Pizzo, Director, Ph.D
Calvin Roberts, Director, Ph.D
C Myers, CEO
David Burke, President
Philip Ashman, Managing Director, Ph.D
David Holland, Founder
Kenneth Green, SVP, Ph.D
Richard Eiswirth, CFO
Brian Halak, Director, Ph.D
Daniel Myers, CEO
Mark Brooks, Director, MBA
Rich Cockrell, President

Stock Performance

Alimera Sciences Performance Indicators